Exact Sciences
EXAS
#1174
Rank
NZ$34.07 B
Marketcap
NZ$178.51
Share price
0.00%
Change (1 day)
140.68%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

EPS for Exact Sciences (EXAS)

EPS in 2025 (TTM): NZ-$9.42

According to Exact Sciences's latest financial reports the company's current EPS (TTM) is NZ-$9.05. In 2024 the company made an earnings per share (EPS) of NZ-$9.48.

EPS history for Exact Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$9.42-0.59%
2024NZ-$9.48
2022NZ-$6.022.31%
2021NZ-$5.89-38.54%
2020NZ-$9.58692.96%
2019NZ-$1.21-50.69%
2018NZ-$2.4544%
2017NZ-$1.70-39.39%
2016NZ-$2.81-2.94%
2015NZ-$2.8937.1%
2014NZ-$2.1179.71%
2013NZ-$1.17-21.59%
2012NZ-$1.50

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
NZ$3.51-138.82%๐Ÿ‡ซ๐Ÿ‡ท France
Veracyte
VCYT
NZ$1.43-115.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
NZ$0.58-106.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
NZ-$7.37-18.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
NZ-$86.61 856.77%๐Ÿ‡บ๐Ÿ‡ธ USA